640 related articles for article (PubMed ID: 16115743)
1. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants.
McFarlane D; Beech J; Cribb A
Domest Anim Endocrinol; 2006 May; 30(4):276-88. PubMed ID: 16115743
[TBL] [Abstract][Full Text] [Related]
2. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
Beech J; Boston R; Lindborg S; Russell GE
J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
[TBL] [Abstract][Full Text] [Related]
3. α-Melanocyte--stimulating hormone and adrenocorticotropin concentrations in response to thyrotropin-releasing hormone and comparison with adrenocorticotropin concentration after domperidone administration in healthy horses and horses with pituitary pars intermedia dysfunction.
Beech J; McFarlane D; Lindborg S; Sojka JE; Boston RC
J Am Vet Med Assoc; 2011 May; 238(10):1305-15. PubMed ID: 21568777
[TBL] [Abstract][Full Text] [Related]
4. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of plasma ACTH, alpha-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction.
Beech J; Boston RC; McFarlane D; Lindborg S
J Am Vet Med Assoc; 2009 Sep; 235(6):715-22. PubMed ID: 19751169
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction.
Beech J; Boston R; Lindborg S
J Vet Intern Med; 2011; 25(6):1431-8. PubMed ID: 22092639
[TBL] [Abstract][Full Text] [Related]
7. Expression of three proopiomelanocortin subtype genes and mass spectrometric identification of POMC-derived peptides in pars distalis and pars intermedia of barfin flounder pituitary.
Takahashi A; Amano M; Amiya N; Yamanome T; Yamamori K; Kawauchi H
Gen Comp Endocrinol; 2006 Feb; 145(3):280-6. PubMed ID: 16242690
[TBL] [Abstract][Full Text] [Related]
8. Seasonal changes in plasma adrenocorticotropic hormone and α-melanocyte-stimulating hormone in response to thyrotropin-releasing hormone in normal, aged horses.
Funk RA; Stewart AJ; Wooldridge AA; Kwessi E; Kemppainen RJ; Behrend EN; Zhong Q; Johnson AK
J Vet Intern Med; 2011; 25(3):579-85. PubMed ID: 21457320
[TBL] [Abstract][Full Text] [Related]
9. Circadian and circannual rhythms of cortisol, ACTH, and α-melanocyte-stimulating hormone in healthy horses.
Cordero M; Brorsen BW; McFarlane D
Domest Anim Endocrinol; 2012 Nov; 43(4):317-24. PubMed ID: 22717182
[TBL] [Abstract][Full Text] [Related]
10. Comparison of in vivo and in vitro corticotropin-releasing hormone-stimulated release of proopiomelanocortin-derived peptides in cats.
Willemse T; Mol JA
Am J Vet Res; 1994 Dec; 55(12):1677-81. PubMed ID: 7887510
[TBL] [Abstract][Full Text] [Related]
11. Profiles of pro-opiomelanocortin and encoded peptides, and their processing enzymes in equine pituitary pars intermedia dysfunction.
Carmalt JL; Mortazavi S; McOnie RC; Allen AL; Unniappan S
PLoS One; 2018; 13(1):e0190796. PubMed ID: 29309431
[TBL] [Abstract][Full Text] [Related]
12. Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction.
Miller MA; Pardo ID; Jackson LP; Moore GE; Sojka JE
Vet Pathol; 2008 Jan; 45(1):26-38. PubMed ID: 18192571
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic testing for pituitary pars intermedia dysfunction in horses.
Dybdal NO; Hargreaves KM; Madigan JE; Gribble DH; Kennedy PC; Stabenfeldt GH
J Am Vet Med Assoc; 1994 Feb; 204(4):627-32. PubMed ID: 8163420
[TBL] [Abstract][Full Text] [Related]
14. Pituitary and interrenal function in gilthead sea bream (Sparus aurata L., Teleostei) after handling and confinement stress.
Rotllant J; Balm PH; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
Gen Comp Endocrinol; 2001 Mar; 121(3):333-42. PubMed ID: 11254375
[TBL] [Abstract][Full Text] [Related]
15. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: diurnal rhythm and responses to various stimuli.
Orth DN; Peterson ME; Drucker WD
Endocrinology; 1988 Apr; 122(4):1250-62. PubMed ID: 3126032
[TBL] [Abstract][Full Text] [Related]
16. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses.
Wilson MG; Nicholson WE; Holscher MA; Sherrell BJ; Mount CD; Orth DN
Endocrinology; 1982 Mar; 110(3):941-54. PubMed ID: 6276164
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of seasonal influences on adrenocorticotropic hormone response to the thyrotropin-releasing hormone stimulation test and its accuracy for diagnosis of pituitary pars intermedia dysfunction.
Adams AA; Siard-Altman MH; Reedy SE; Barker D; Elzinga S; Sanz MG; Urschel K; Ireland JL
Vet J; 2023; 300-302():106035. PubMed ID: 37802466
[TBL] [Abstract][Full Text] [Related]
18. Systemic and pituitary pars intermedia antioxidant capacity associated with pars intermedia oxidative stress and dysfunction in horses.
McFarlane D; Cribb AE
Am J Vet Res; 2005 Dec; 66(12):2065-72. PubMed ID: 16379648
[TBL] [Abstract][Full Text] [Related]
19. Results of a combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test in healthy horses and horses suspected to have a pars intermedia pituitary adenoma.
Eiler H; Oliver JW; Andrews FM; Fecteau KA; Green EM; McCracken M
J Am Vet Med Assoc; 1997 Jul; 211(1):79-81. PubMed ID: 9215417
[TBL] [Abstract][Full Text] [Related]
20. The effect of freeze-thaw cycles on determination of immunoreactive plasma adrenocorticotrophic hormone concentrations in horses.
Hu K; Stewart AJ; Yuen KY; Hinrichsen S; Dryburgh EL; Bertin FR
J Vet Intern Med; 2020 May; 34(3):1350-1356. PubMed ID: 32255541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]